Form 4 for MGNX MACROGENICS INC
Accepted 2026-08-18 16:19:05 ET · period of report 2026-08-17 · accession 0001588365-26-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-18 16:19 | 2026-08-17 | MGNX | Bonvini Ezio | SVP, CSO, Research | M - OptEx | $2.60 | +40.0K | 185.8K | +27% | +$104.0K |
| D | 2026-08-18 16:19 | 2026-08-17 | MGNX | Bonvini Ezio | SVP, CSO, Research | M - OptEx | $2.60 | -40.0K | 88.0K | -31% | -$104.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-17 | M | A | 40,000 | $2.60 | 185,799 | D | — | — | (F1) The transaction represents an exercise and hold of options. |
| 2 | Derivative | Employee Stock Option (right to buy) | 2026-08-17 | M | D | 40,000 | $2.60 | 88,000 | D | $2.60 · — to 2035-02-07 | 40,000 Common Stock | (F2) 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter. |